Abstract:Objective To explore the relationship between routine coagulation test (CCT), thromboelastography (TEG), and platelet transfusion bleeding in patients with immune thrombocytopenia.Methods A retrospective analysis was conducted on the clinical data of 156 patients with immune thrombocytopenia who underwent platelet transfusion at Shaanxi Nuclear Industry 215 Hospital from January 2021 to August 2024. According to the bleeding situation after platelet transfusion in all patients, they were divided into a bleeding group (n = 50) and a non bleeding group (n = 106). Compare the differences between two sets of general information [gender, age, acute physiology and chronic health score (APACHE Ⅱ), disease staging, blood type, underlying diseases], TEG indicators [coagulation reaction time (R) value, blood clot formation time (K) value, coagulation angle (Angle), maximum amplitude (MA) value, and CCT indicators [activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT), fibrinogen (FIB)] levels. Non conditional logistic stepwise regression analysis was conducted using multiple factors to identify the risk factors for post transfusion bleeding in patients with immune thrombocytopenia. Finally, ROC analysis was used to predict the value of post transfusion bleeding in immune thrombocytopenia patients based on K value, Angle, MA value, PT, and FIB levels.Results The comparison of K value, PT level, Angle, MA value, and FIB level between the bleeding group and the non bleeding group showed statistically significant differences (P < 0.05) through t-test; The K value and PT level in the bleeding group were higher than those in the non bleeding group, while the Angle, MA value, and FIB level were lower than those in the non bleeding group (P < 0.05). Multivariate logistic analysis showed that high K value [O^R =13.265 (95% CI: 2.985, 58.948) ], low MA value [O^R = 7.261 (95% CI: 1.124, 46.906) ], low Angle [O^R = 11.124 (95% CI: 2.564, 48.262) ], low FIB level [O^R = 9.561 (95% CI: 2.135, 42.816) ], and high PT level [O^R = 10.561 (95% CI: 2.263, 49.286) ] are risk factors for platelet transfusion bleeding in patients with immune thrombocytopenia (P < 0.05). ROC analysis confirmed that K value, Angle, MA value, PT, and FIB levels can all be used for predicting platelet transfusion bleeding in patients with immune thrombocytopenia. Their sensitivities were 80.0% (95% CI: 0.721, 0.843), 72.0% (95% CI: 0.683, 0.803), 80.0% (95% CI: 0.685, 0.803), 64.0% (95% CI: 0.602, 0.715), 72.0% (95% CI: 0.675, 0.796), and specificities were 81.1% (95% CI: 0.726, 0.861), 79.2% (95% CI: 0.764, 0.832), 86.8% (95% CI: 0.820, 0.892), and 77.4% (95% CI: 0.732, 0.863), respectively. 77.4% (95% CI: 0.721, 0.853).Conclusion The bleeding after platelet transfusion in patients with immune thrombocytopenia is closely related to K value, Angle, MA value, PT, and FIB levels, and should be closely monitored clinically.